Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Positive Controlled Trial That Assess the Safety And Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in Moderate and Severe Plaque Psoriasis Patients

NCT03424629 is registered in ClinicalTrials.gov with Tianjin Ever Union Biotechnology Co., Ltd. as lead sponsor.

NCT NCT03424629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03424629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Positive Controlled Trial That Assess the Safety And Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in Moderate and Severe Plaque Psoriasis Patients
Lead sponsor
Tianjin Ever Union Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
June 1, 2018
Completion date
December 31, 2019
Enrollment
57 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

moderate and severe plaque psoriasis